These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 11550501)

  • 1. [Effect of antibacterial therapy on the epidemic threat of experimental pneumonic plague in monkeys].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV
    Antibiot Khimioter; 2001; 46(4):16-8. PubMed ID: 11550501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Evaluation of the effectiveness of antibacterial substances in treating an experimental form of bubonic plague in monkeys].
    Romanov VE; Evstigneev VI; Vasil'ev NT; Shabalin BA; Paramonov VE
    Antibiot Khimioter; 2001; 46(8):6-8. PubMed ID: 11871319
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Yersinia pestis and plague - an update].
    Stock I
    Med Monatsschr Pharm; 2014 Dec; 37(12):441-8; quiz 449. PubMed ID: 25643450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of an in vitro pharmacodynamic model to derive a moxifloxacin regimen that optimizes kill of Yersinia pestis and prevents emergence of resistance.
    Louie A; Heine HS; VanScoy B; Eichas A; Files K; Fikes S; Brown DL; Liu W; Kinzig-Schippers M; Sörgel F; Drusano GL
    Antimicrob Agents Chemother; 2011 Feb; 55(2):822-30. PubMed ID: 21115791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activities of 14 antibiotics against 100 human isolates of Yersinia pestis from a southern African plague focus.
    Frean JA; Arntzen L; Capper T; Bryskier A; Klugman KP
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2646-7. PubMed ID: 8913481
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial filamentation of Yersinia pestis by beta-lactam antibiotics in experimentally infected mice.
    Davis KJ; Vogel P; Fritz DL; Steele KE; Pitt ML; Welkos SL; Friedlander AM; Byrne WR
    Arch Pathol Lab Med; 1997 Aug; 121(8):865-8. PubMed ID: 9278616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro antibiotic susceptibilities of Yersinia pestis determined by broth microdilution following CLSI methods.
    Heine HS; Hershfield J; Marchand C; Miller L; Halasohoris S; Purcell BK; Worsham PL
    Antimicrob Agents Chemother; 2015 Apr; 59(4):1919-21. PubMed ID: 25583720
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Laboratory studies on Yersinia pestis during the 1991 outbreak of plague in Lushoto, Tanzania.
    Lyamuya EF; Nyanda P; Mohammedali H; Mhalu FS
    J Trop Med Hyg; 1992 Oct; 95(5):335-8. PubMed ID: 1404556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The sensitivity of plague agent from Siberian natural focuses of disease to antibacterial preparations in vitro].
    Balakhonov SV; Bel'kova SA; Tokmakova EG; Khvoĭnova IG; Zakhlebnaia OD
    Klin Lab Diagn; 2013 Apr; (4):36-40. PubMed ID: 23984554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic susceptibilities of 94 isolates of Yersinia pestis to 24 antimicrobial agents.
    Hernandez E; Girardet M; Ramisse F; Vidal D; Cavallo JD
    J Antimicrob Chemother; 2003 Dec; 52(6):1029-31. PubMed ID: 14613959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of 2 antibiotics that inhibit protein synthesis for the treatment of infection with Yersinia pestis delivered by aerosol in a mouse model of pneumonic plague.
    Heine HS; Louie A; Sorgel F; Bassett J; Miller L; Sullivan LJ; Kinzig-Schippers M; Drusano GL
    J Infect Dis; 2007 Sep; 196(5):782-7. PubMed ID: 17674322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of resistance selection and mutant growth fitness on the relative efficacies of streptomycin and levofloxacin for plague therapy.
    Louie A; Deziel MR; Liu W; Drusano GL
    Antimicrob Agents Chemother; 2007 Aug; 51(8):2661-7. PubMed ID: 17517837
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Isepamycin in prophylaxis and treatment of experimental plague due to FI+ and FI- variants of plague microbe].
    Smorodinova IuV; Shcherbaniuk AI; Ryzhko IV; Moldavan IA
    Antibiot Khimioter; 2005; 50(8-9):23-6. PubMed ID: 17016907
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transmission of Antimicrobial Resistant Yersinia pestis During a Pneumonic Plague Outbreak.
    Andrianaivoarimanana V; Wagner DM; Birdsell DN; Nikolay B; Rakotoarimanana F; Randriantseheno LN; Vogler AJ; Sahl JW; Hall CM; Somprasong N; Cauchemez S; Schweizer HP; Razafimandimby H; Rogier C; Rajerison M
    Clin Infect Dis; 2022 Mar; 74(4):695-702. PubMed ID: 34244722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enrichment of Yersinia pestis from blood cultures enables rapid antimicrobial susceptibility determination by flow cytometry.
    Steinberger-Levy I; Zahavy E; Cohen S; Flashner Y; Mamroud E; Aftalion M; Gur D; Ber R
    Adv Exp Med Biol; 2007; 603():339-50. PubMed ID: 17966430
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Standardization of conditions for the evaluation of effectiveness of antibacterial drugs in pneumonic plague in sacred baboons].
    Romanov VE; Vasil'ev NT; Shabalin BA; Mironin AV; Paramonov VE
    Antibiot Khimioter; 1995 Jun; 40(6):23-30. PubMed ID: 8593090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of doxycycline and ciprofloxacin against experimental Yersinia pestis infection.
    Russell P; Eley SM; Green M; Stagg AJ; Taylor RR; Nelson M; Beedham RJ; Bell DL; Rogers D; Whittington D; Titball RW
    J Antimicrob Chemother; 1998 Feb; 41(2):301-5. PubMed ID: 9533478
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of the latest fluoroquinolones against experimental Yersinia pestis.
    Steward J; Lever MS; Russell P; Beedham RJ; Stagg AJ; Taylor RR; Brooks TJ
    Int J Antimicrob Agents; 2004 Dec; 24(6):609-12. PubMed ID: 15555886
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gepotidacin is efficacious in a nonhuman primate model of pneumonic plague.
    Jakielaszek C; Hossain M; Qian L; Fishman C; Widdowson K; Hilliard JJ; Mannino F; Raychaudhuri A; Carniel E; Demons S; Heine HS; Hershfield J; Russo R; Mega WM; Revelli D; O'Dwyer K
    Sci Transl Med; 2022 Jun; 14(647):eabg1787. PubMed ID: 35648812
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chromosomal resistance of plague agent to quinolones].
    Kasatkina IV; Shcherbaniuk AI; Makarovskaia LN; Padeĭskaia EN
    Antibiot Khimioter; 1991 Aug; 36(8):35-7. PubMed ID: 1661573
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.